The results showed that NUMB protein levels were lower in the subset of breast cancer samples with poor prognostic parameters, such as ER-negative (p < 0.001), HER2-positive (p = 0.016) and triple-negative (p = 0.023) phenotypes (Figure 8A and Table 1). This evidence concerns the gene ERBB2 and breast carcinoma.